As a B-cell lymphoma-2 (Bcl-2) anti-apoptotic protein inhibitor, ABT737 has been shown to have potent anti-tumor effects against several types of tumors, including HCC [22]. This evidence concerns the gene BCL2 and hepatocellular carcinoma.